
Richard J Kovacs MD MACC (He/Him)
Cardiac Electrophysiology, Non-Invasive Cardiology, Clinical Pharmacology
Q.E. and Sally Russell Professor, Indiana University School of Medicine Chief Medical Officer American College of Cardiology
Join to View Full Profile
1801 N Senate BlvdE379Indianapolis, IN 46202
Phone+1 317-962-0551
Fax+1 317-962-0065
Dr. Kovacs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Kovacs, located in Indianapolis, IN, specializes in Cardiology with subspecialties in Non-Invasive Cardiology and Clinical Pharmacology. He completed his fellowship in Cardiovascular Disease and residency in Internal Medicine at Indiana University School of Medicine, following his graduation from the University of Cincinnati College of Medicine in 1980. Currently serving as Chief Medical Officer at the American College of Cardiology, Dr. Kovacs has extensive experience in drug safety, long QT syndrome, health policy, and sports cardiology. He also is the Interim Chief of the Division of Cardiology at Indiana University School of Medicine and as the Interim Director of the IU Health / Indiana University School of Medicine Cardiovascular Institute. His recent publications appear in prominent journals such as JACC and Circulation. Dr. Kovacs has led clinical trials related to atrial fibrillation and cognitive impairments. He has been recognized with several honors, including being named a Master by the American College of Cardiology and receiving the Sagamore of the Wabash award.
Education & Training
Indiana University School of MedicineResidency, Internal Medicine, 1985 - 1986
Indiana University School of MedicineFellowship, Cardiovascular Disease, 1982 - 1985
Indiana University School of MedicineResidency, Internal Medicine, 1980 - 1982
University of Cincinnati College of MedicineClass of 1980
Certifications & Licensure
IN State Medical License 1982 - 2027
MI State Medical License 2007 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Alpha Omega Alpha 2023
- Regional Top Doctor Castle Connolly, 2014-2022
- Master American College of Cardiology, 2020
Clinical Trials
- The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia Start of enrollment: 2013 Jun 01
- Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening Start of enrollment: 2013 Apr 01
- A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia Start of enrollment: 2014 Mar 26
Publications & Presentations
PubMed
- Effects of High- Versus Low-Sodium Oxybate on Blood Pressure in Patients With Narcolepsy.William B White, Richard J Kovacs, Jessica K Alexander, Christine Baranak, Deborah A Nichols
Hypertension. 2025-12-01 - Dihydrotestosterone Pretreatment Diminishes the Severity of Drug-Induced Torsades de Pointes.James E Tisdale, Heather A Jaynes, Brian R Overholser, Kevin M Sowinski, Richard J Kovacs
Journal of Cardiovascular Pharmacology. 2025-10-01 - 4 citationsAre high school cardiopulmonary resuscitation education mandates working? Insights from a high school survey on CPR knowledge, attitudes, and readiness.Aashish Katapadi, Danish Bawa, Jalaj Garg, Avani Lakkireddy, Adnan Ahmed
Heart Rhythm. 2025-07-01
Journal Articles
- Finding Refuge in the ACC Family in Unprecedented TimesRichard Kovacs, MD, JACC: Cardiovascular Imaging
Authored Content
- Finding Refuge in the ACC Family in Unprecedented TimesMay 2020
Press Mentions
FDA Updates CV Warnings Around COVID-19 mRNA VaccinesJune 26th, 2025
Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav® (Calcium, Magnesium, Potassium, and Sodium Oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025June 9th, 2025
CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 DrugsNovember 27th, 2024
Committees
- member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









